Looming Amylyx drug approval decision renews debate over ALS endpoints

Looming Amylyx drug approval decision renews debate over ALS endpoints

Submitted by admin on September 15, 2022 - 10:35am
Source: 
Clinical Trials Arena
News Tags: 
Amylyx Pharmaceuticals
AMX-0035
ALS
clinical trials
Headline: 
Looming Amylyx drug approval decision renews debate over ALS endpoints
snippet: 

With the FDA's decision on Amylyx’s AMX-0035 fast approaching, we dive into tensions over ALS endpoints and major drug trials to watch.

Do Not Allow Advertisers to Use My Personal information